The company’s stock rose in its first two days on public markets, closing on Monday up almost 58% over the IPO price amid ...

Heartflow, a company involved in AI technology for coronary artery disease, went public on Friday under the ticker symbol HTFL, raising $316.7 million with its initial public offering. Late last week, ...

HeartFlow joins a group of medtechs planning to go public in 2025, including Medtronic’s new standalone diabetes business and ...

HeartFlow Inc. (HTFL) completed its initial public offering, raising approximately $364.2 million in gross proceeds before fees and expenses, according to a company statement.

Heartflow has priced its previously announced initial public offering (IPO), with proceeds potentially reaching up to $300 ...

Medical technology company Heartflow said on Wednesday it was targeting a valuation of up to $1.46 billion in its upsized ...

Backed by Bain Capital, the health technology startup makes 3D models of people's hearts to help diagnose diseases. Here's ...

HeartFlow’s AI-based CAD platform targets a large market with strong adoption, but IPO valuation and risks warrant caution.

Medtech firm Heartflow was valued at $2.27 billion on Friday, with its shares surging 47.4% in the Nasdaq debut, as the IPO ...

Heartflow is advancing coronary care by transforming coronary artery disease into a screenable, diagnosable, and manageable ...

Seven IPOs and two SPACs debuted this week, while five small IPOs and seven SPACs submitted initial filings. Read more here.

(Reuters) -Cardiac diagnostic software maker Heartflow said on Friday it was targeting a valuation of up to $1.32 billion in ...